Browse: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | 1 | 3 |
Amgen Inc. patentsThe following is a sampling of recent Amgen Inc. patent applications (USPTO Patent Application #, Patent Title) sorted by month.
April 2009 - Amgen Inc. patents
20080261968 - Heterobicyclic metalloprotease inhibitors
20080255145 - Thiadiazole compounds and methods of use
20080255181 - Methods for treating podocyte-related disorders
20080255205 - Multi-cyclic compounds and methods of use
20080249090 - Substituted pyridone compounds and methods of use
20080249106 - Novel b1 bradykinin receptor antagonists
20080241096 - Il-1 family variants
March 2009 - Amgen Inc. patents
20080234268 - Bis-aryl amide derivatives and methods of use
20080227779 - Heterocyclic compounds and methods of use
20080221083 - Heterobicyclic metalloprotease inhibitors
20080221091 - Metalloprotease inhibitors containing a heterocyclic moiety
20080221092 - Heterobicyclic metalloprotease inhibitors
20080221093 - Metalloprotease inhibitors containing a heterocyclic moiety
20080221094 - Metalloprotease inhibitors containing a squaramide moiety
20080221095 - Metalloprotease inhibitors containing a heterocyclic moiety
20080221101 - Calcium receptor modulating agents
20080221128 - Metalloprotease inhibitors containing a squaramide moiety
20080213282 - Formulations
20080214544 - Substituted heterocycles and methods of use
20080214795 - Method of isolating antibodies by precipitation
February 2009 - Amgen Inc. patents
20080207607 - Heterotricyclic metalloprotease inhibitors
20080200464 - Substituted heterocycles and methods of use
20080188417 - Beta-like glycoprotein hormone polypeptide and heterodimer
January 2009 - Amgen Inc. patents
20080176870 - Heterobicyclic metalloprotease inhibitors
20080166768 - Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
20080167450 - Methods of purifying proteins
20080161300 - Heterobicyclic metalloprotease inhibitors
20080161303 - Imidazo- and triazolo-pyridine compounds and methods of use thereof
20080161346 - Compounds and methods of use
December 2008 - Amgen Inc. patents
20080152651 - Novel polypeptides involved in immune response
November 2008 - Amgen Inc. patents
20080124326 - Stable polypeptide formulations
20080125424 - Derivatives of urea and related diamines, methods for their manufacture, and uses therefor
20080119468 - Phthalazine, aza-and diaza-phthalazine compounds and methods of use
20080119511 - Benzo-fused compounds for use in treating metabolic disorders
20080112953 - Stable formulations
20080108664 - Solid-state form of amg 706 and pharmaceutical compositions thereof
20080102492 - Methods and compositions for the prevention and treatment of anemia
October 2008 - Amgen Inc. patents
20080261968 - Heterobicyclic metalloprotease inhibitors
20080255145 - Thiadiazole compounds and methods of use
20080255181 - Methods for treating podocyte-related disorders
20080255205 - Multi-cyclic compounds and methods of use
20080249090 - Substituted pyridone compounds and methods of use
20080249106 - Novel b1 bradykinin receptor antagonists
20080241096 - Il-1 family variants
September 2008 - Amgen Inc. patents
20080234268 - Bis-aryl amide derivatives and methods of use
20080227779 - Heterocyclic compounds and methods of use
20080221083 - Heterobicyclic metalloprotease inhibitors
20080221091 - Metalloprotease inhibitors containing a heterocyclic moiety
20080221092 - Heterobicyclic metalloprotease inhibitors
20080221093 - Metalloprotease inhibitors containing a heterocyclic moiety
20080221094 - Metalloprotease inhibitors containing a squaramide moiety
20080221095 - Metalloprotease inhibitors containing a heterocyclic moiety
20080221101 - Calcium receptor modulating agents
20080221128 - Metalloprotease inhibitors containing a squaramide moiety
20080213282 - Formulations
20080214544 - Substituted heterocycles and methods of use
20080214795 - Method of isolating antibodies by precipitation
August 2008 - Amgen Inc. patents
20080207607 - Heterotricyclic metalloprotease inhibitors
20080200464 - Substituted heterocycles and methods of use
20080188417 - Beta-like glycoprotein hormone polypeptide and heterodimer
July 2008 - Amgen Inc. patents
20080176870 - Heterobicyclic metalloprotease inhibitors
20080166768 - Nucleic acid molecules encoding beta-like glycoprotein hormone polypeptide and heterodimer thereof
20080167450 - Methods of purifying proteins
20080161300 - Heterobicyclic metalloprotease inhibitors
20080161303 - Imidazo- and triazolo-pyridine compounds and methods of use thereof
20080161346 - Compounds and methods of use
June 2008 - Amgen Inc. patents
20080152651 - Novel polypeptides involved in immune response
May 2008 - Amgen Inc. patents
20080124326 - Stable polypeptide formulations
20080125424 - Derivatives of urea and related diamines, methods for their manufacture, and uses therefor
20080119468 - Phthalazine, aza-and diaza-phthalazine compounds and methods of use
20080119511 - Benzo-fused compounds for use in treating metabolic disorders
20080112953 - Stable formulations
20080108664 - Solid-state form of amg 706 and pharmaceutical compositions thereof
20080102492 - Methods and compositions for the prevention and treatment of anemia
April 2008 - Amgen Inc. patents
20080096900 - Methods for treating atherosclerosis
20080090840 - Heterocyclic gpr40 modulators
March 2008 - Amgen Inc. patents
20080070840 - Thrombopoietic compounds
20080057515 - Beta-like glycoprotein hormone polypeptide and heterodimer
February 2008 - Amgen Inc. patents
20080051453 - Sorbic acid analog co-crystals
20080039501 - Hydrate forms of amg706
20080032973 - 2-quinazolinone compounds and methods of use
20080032977 - Alkyne-substituted pyridone compounds and methods of use
20080032988 - Thieno-[2,3-d]pyrimidine and thieno-pyridazine compounds and methods of use
January 2008 - Amgen Inc. patents
20080020978 - Cgrp peptide antagonists and conjugates
20080021024 - Metalloprotease inhibitors
20080003611 - Heat lysis production of proteins
20080004289 - Glycine transporter-1 inhibitors
November 2007 - Amgen Inc. patents
20070269369 - Modified fc molecules
20070265248 - Substituted piperazines and methods of use
20070253951 - Humanized c-kit antibody
October 2007 - Amgen Inc. patents
20070248597 - Methods of decreasing vascular calcification using il-1 inhibitors
20070244155 - Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
September 2007 - Amgen Inc. patents
20070213325 - Multi-cyclic compound and method of use
August 2007 - Amgen Inc. patents
20070190057 - Methods for modulating mannose content of recombinant proteins
20070191298 - Beta secretase genes
20070185103 - Beta-secretase modulators and methods of use
20070185111 - Aurora kinase modulators and method of use
20070185133 - Aminopyrimidine compounds and methods of use
20070185144 - Beta-secretase modulators and methods of use
20070185171 - Compounds and methods of use
20070185324 - Nitrogen-containing bicyclic heteroaryl compounds and methods of use
20070179134 - Urea derivatives, processes for their preparation, their use as medicaments, and pharmaceutical compositions containing them
July 2007 - Amgen Inc. patents
20070173477 - Beta secretase polypeptides
20070173502 - Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
20070173506 - Thiazole compounds and methods of use
20070173521 - Beta-secretase modulators and methods of use
June 2007 - Amgen Inc. patents
20070149513 - Vanilloid receptor ligands and their use in treatments
20070149557 - Cxcr3 antagonists
20070142381 - Calcium receptor modulating agents
20070142384 - Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
May 2007 - Amgen Inc. patents
20070110802 - Wet granulation process
20070105199 - Methods for generating monovalent igg
March 2007 - Amgen Inc. patents
20070049532 - Modified peptides as therapeutic agents
20070049592 - Bis-aryl urea compounds and methods of use
February 2007 - Amgen Inc. patents
20070025993 - Tek antagonists
20070026497 - Method for controlling metallophosphate precipitation in high cell density fermentations
December 2006 - Amgen Inc. patents
20060275285 - Methods of inhibiting a gpcr
20060276534 - Methods of decreasing calcification
November 2006 - Amgen Inc. patents
20060270724 - Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
20060264377 - Chemically modified novel erythropoietin stimulating protein compositions and methods
20060264424 - Arylsulfonamidobenzylic compounds
20060264481 - Therapeutic modulation of ppargamma activity
20060252777 - Substituted heterocycles and methods of use
20060246064 - Osteoprotegerin binding proteins
20060247263 - Substituted heterocyclic compounds and methods of use
October 2006 - Amgen Inc. patents
20060241115 - Compounds and methods of use
20060241296 - Vanilloid receptor ligands and their use in treatments
20060234307 - Modified peptides as therapeutic agents
20060235036 - Vanilloid receptor ligands and their use in treatments
September 2006 - Amgen Inc. patents
20060216288 - Combinations for the treatment of cancer
20060211022 - Detection of compounds that affect therapeutic activity
20060199796 - Substituted benzofused heterocycles
20060199812 - Method of conjugating aminothiol containing molecules to vehicles
20060199817 - Phthalazine, aza- and diaza-phthalazine compounds and methods of use
###
This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Amgen Inc. in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Amgen Inc. with additional patents listed. Browse our Agent directory for other possible listings.
###
FreshPatents.com Support
|
REGISTER now for FREE 
